Email
Print
Musculoskeletal Diseases Market By Type (Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Tendinitis, Carpel tunnel syndrome, Bone fractures, Osteomalacia, & Others), By Medication (Acetaminophen, Nonsteroidal anti-inflammatory drugs (NSAIDs), Anti-neuropathic pain medications, Corticosteroids, Biologics & biosimilars, Osteoporosis medications, Gout medications, Fibromyalgia medications, & Others. By Treatment - Forecast(2024 - 2030)
Musculoskeletal Diseases Market Overview
Musculoskeletal Diseases Market Size is estimated to reach $9650 Million by 2030 and is poised to grow at a CAGR of 6.90% over the forecast period of 2024-2030.
Musculoskeletal disorders (MSD) are injuries or disorders of the muscles, nerves, tendons, joints, cartilage, and spinal discs. The Department of Labor's Bureau of Labor Statistics defines MSDs as a musculoskeletal system and connective tissue diseases and disorders when the exposure or event that caused the condition was repetitive motion, overexertion, or bodily reaction such as bending, climbing, crawling, reaching, or twisting. Disorders caused by falls, trips, slips, and other similar events are not included in MSDs. The three most prevalent musculoskeletal diseases, according to reports published by bone and joint disease organizations, are arthritis, back pain, and trauma. Each year, patients seek treatment for these conditions in hospitals, emergency care, and physician practices. Major musculoskeletal diseases are more expensive to treat than many other common medical conditions as they frequently cause long-term pain and disability. According to a recent review of Global Burden of Disease (GBD) 2019 data, 1.71 billion individuals worldwide suffer from musculoskeletal disorders such as rheumatoid arthritis, osteoarthritis, low back pain, neck discomfort, fractures, and other injuries. Such global prevalence of musculoskeletal disease and their increasing cases with most of population in majority of countries turns towards older age contribute to new research and development in musculoskeletal disease. Some major groups like Zimmer Biomet holdings, Inc., Stryker Corporation, Medtronic, Wright Medical group and others contribute to the growth of the Musculoskeletal Disease Industry over the forecast period 2024-2030.
Musculoskeletal Diseases Market Report Coverage
The report: “Musculoskeletal Diseases Market Forecast (2024-2030)", by Industry ARC covers an in-depth analysis of the following segments in the Musculoskeletal Diseases Market.
Key Takeaways
- Geographically, North America held a dominant market share in the year 2021, owing to the increasing prevalence of Inflammatory Bowel Diseases, and developed healthcare facilities assist the growth of the Musculoskeletal Diseases Market Size in this region.
- The rising awareness about the musculoskeletal disease among the population drives the growth of the Musculoskeletal Diseases Market Size.
- However, the high price of treatment may limit market growth over the forecast period 2024-2030.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Musculoskeletal Diseases Market Report.
Musculoskeletal Diseases Market: Market Share (%) by region, 2021.
For More Details on This Report - Request for Sample
Musculoskeletal Diseases Market Segment Analysis- By Type
The Musculoskeletal Diseases Market based on type can be further segmented into Rheumatoid Arthritis, Osteoarthritis, Osteoporosis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, Tendinitis, Carpel tunnel syndrome, Bone fractures, Osteomalacia, and Others. Rheumatoid Arthritis held a dominant market share in the year 2021. This is owing to the growing prevalence of rheumatoid arthritis over the globe. According to the arthritis organization about 1.5 million people in the United States living with rheumatoid arthritis in 2021. As per World Health Organization, in 2021, about 14 million people are living with rheumatoid arthritis. Such a growing prevalence of rheumatoid arthritis drives the growth of the Musculoskeletal Disease Market Share.
However, Bone Facture is estimated to grow with the fastest CAGR rate of 7.8% over the forecast period 2022-2027. This is the result of the rising number of road accidents, worksite injuries and violence around the world. As per Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019, about 178 million new facture cases, 455 million prevalent cases of acute or long-term symptoms of a fractures, and 25.8 million Years Lived with Disabilities (YLDs) were reported. Osteoporosis is also leading cause of bone factures and responsible for 8.9 million factures annually according to Bone Health 2022 report published in Taylor & Francis Online Journal. Such growing cases of bone fractures fuels growth of Musculoskeletal Disease Market Share over the forecast period 2024-2030.
Musculoskeletal Diseases Market Segment Analysis- By End Users
Musculoskeletal Diseases Market based on the end users can be further segmented into Hospitals, Diagnostics Centers, Urgent Care Centers, Physiotherapy, and Clinics. The Hospitals segment held a dominant market share in the year 2021. This is the result of growing number of hospitals chain and better healthcare infrastructure all over the world. Also, a growing number of specialty orthopedic hospitals assist the growth of the market. The U.S News and World Report Assessed 1660 hospitals for 2021-22 rankings with Hospitals for special surgery. Such a growing number of specialty hospitals and increasing spending on health care infrastructure drive the growth of the Musculoskeletal Disease Market share.
However, Urgent Care Centers is estimated to grow with the fastest CAGR rate of 7.4% over the forecast period 2022-2027. This is owing to the increasing number of urgent care centers across the globe. As a musculoskeletal disease covered a broad range of sub diseases like rheumatoid arthritis, osteoarthritis, osteoporosis, spondylitis, fibromyalgia, arthralgia, and others. According to an EpiCast report the U.S, has the highest number of diagnosed prevalent cases of ankylosing spondylitis, with 608,813 diagnosed prevalent cases in 2022. Also, as per arthritis statistics by single care 2022, more than 350 million people have arthritis globally in 2021, and Fibromyalgia affects 4 million U.S. adults, and 60% of people who have arthritis are between the ages of 18 and 64 as per the data published by Center for Disease Control Prevention in 2020. Such factors create global demand for Musculoskeletal Disease Market Share over the forecast period 2024-2030.
Musculoskeletal Diseases Market Segment Analysis- By Geography
The Musculoskeletal Diseases Market based on Geography can be further segmented into North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 32% in the year 2021. This is owing to growing prevalence of disease like rheumatoid arthritis, osteoarthritis, osteoporosis, spondylitis, fibromyalgia, arthralgia, and others in this region. Musculoskeletal disorders account for nearly 70 million physician office visits in the United States annually, and an estimated 130 million total health care encounters including outpatient, hospital and emergency room visits. Musculoskeletal diseases affect more than one out of every two persons in the United States age 18 and over, and nearly three out of four age 65 and over according to bone and joint organization. The Institute in Medicine estimates the economic burden of WMSDs as measured by compensation costs, lost wages, and lost productivity, is between $45 and $54 billion annually. According to Liberty Mutual, the largest workers’ compensation insurance provider in the United States, overexertion injuries—lifting, pushing, pulling, holding, carrying or throwing an object—cost employers $13.4 billion every year. Such a growing burden of musculoskeletal disease drives the growth of the Musculoskeletal Disease Market Size.
Europe is estimated to grow with the fastest CAGR rate of 8.1% over the forecast period 2022-2022. This is owing to the increasing burden of musculoskeletal diseases in European countries. According to ‘Versus Arthritis’, over 20 million people in the UK which is around a third of the population) live with musculoskeletal (MSK) disease, such as arthritis and low back pain. In England about 17.1 million people, in Scotland 1.7 million, in Wales 974000, and in Northern Ireland 525000 people were affected with musculoskeletal diseases. Such a growing number of cases of musculoskeletal diseases in the European Region fuel the growth of the Musculoskeletal Diseases Market Size over the forecast period 2024-2030.
Musculoskeletal Diseases Market Drivers:
Growing Population of Elderly Peoples Drives the Market Growth.
With the rising population going towards older age and increasing disabilities with increasing age aid market growth. In the majority of nations around the world, most populations are growing towards elder age. Musculoskeletal diseases most prevalently occur above 60 age. One in six persons will be 60 or older by 2030, according to the World Health Organization. Additionally, the Statistics Bureau of Japan reports that in a nation like Japan, where the oldest population in the world resides, up to 29% of the total population are over 65 years old in May 2022. Also, as per World Health Organization (WHO), the share of the population aged 60 years and older will increase from 1 billion in 2020 to 1.4 billion by 2050. Such an increasing elderly population and a growing chance of musculoskeletal diseases in the elderly population fuel growth of the Musculoskeletal Disease Industry.
Growing Number of Musculoskeletal Related Disease Aid Market Growth.
With the increasing prevalence of musculoskeletal disease, there is a significant rise in diseases like, rheumatoid arthritis, osteoarthritis, osteoporosis, spondylitis, fibromyalgia, arthralgia & others; and their increasing number of cases assist growth of the market. According to Medicine Matters, prevalence of osteoarthritis is increased in 204 countries and territories; the study found that in 2019, there were 527.81 million prevalent cases of osteoarthritis globally, and the prevalence is higher in women than men, in women, it is 317.44 million cases in 2019 & in men 210.37 million cases in 2019. Such a growing prevalence of musculoskeletal related disease fuel growth of the Musculoskeletal Disease Industry.
Musculoskeletal Diseases Market Challenges:
High Price of Treatment for Orthopedic Disease is Hampering Market Growth.
In developing countries, the cost of treatment for the orthopedic disease is high in comparison to developed countries. The average cost per patient stayed in King Fahd Central hospital (KFCH) was Saudi Riyal (SAR) 19,034, with the highest cost of SAR 108,561 for patients in the orthopedic ward as per research paper published in the Saudi Journal of Biological Sciences in January 2021. external fixators (EFs) has high range of orthopedic applications. Over 50% of the world’s traumatic injuries occur in low and middle-income countries and external fixation techniques are widely utilized for fracture stabilization in developing countries due to increasing trauma accidents. The mean total cost per patient for EF was $559?±?70.5 in Tanzania. Such a high cost of treatment may stymie the growth of the Musculoskeletal Disease Market over the forecast period 2024-2030.
Musculoskeletal Diseases Market Industry Outlook:
Product launches, mergers and acquisitions, joint ventures, and geographical expansions are key strategies adopted by players in the Musculoskeletal Diseases Market. The top 10 companies in the Musculoskeletal Diseases Market are:
- Zimmer Biomet Holdings, Inc.
- Johnson & Johnson
- Amgen Inc.
- AbbVie Inc
- Bristol-Myers Squibb
Recent Developments
- In July 2022, Mitsubishi Tanabe Pharma Corporation and Eli Lilly Japan announced that the two companies signed a sales collaboration agreement in Japan for Trizepatide which is under development by Eli Lilly Japan. Tirzepatide (injection) is a novel once-weekly GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist that integrates the actions of the GIP and GLP-1 incretins into a single molecule, representing a new class of medicines being developed for the treatment of type 2 diabetes by Eli Lilly Japan.
- In January 2022, Bristol-Myers Squibb announced definitive merger agreement to acquire Turning Point Therapeutics, a clinical-stage precision oncology company with a pipeline of investigational medicines designed to target the most common mutations associated with oncogenesis for $76 per share. This acquisition helps to expand leading oncology franchise of Bristol-Myers Squibb by adding best-in-class, late-stage precision oncology assets.
- In January 2022, Stryker, announced a definitive merger agreement to acquire all of the issued and outstanding shares of common stock of Vocera Communications, Inc. for $79.25 per share, or a total equity value of approximately $2.97 billion and a total enterprise value of approximately $3.09 billion.
Relevant Titles
Report Code: HCR 0044
Report Code: HCR 0907
Report Code: HCR 0698
For more Lifesciences and Healthcare Market reports, please click here
List of Tables:
Table 1: Musculoskeletal Diseases Market Overview 2023-2030
Table 2: Musculoskeletal Diseases Market Leader Analysis 2023-2030 (US$)
Table 3: Musculoskeletal Diseases Market Product Analysis 2023-2030 (US$)
Table 4: Musculoskeletal Diseases Market End User Analysis 2023-2030 (US$)
Table 5: Musculoskeletal Diseases Market Patent Analysis 2013-2023* (US$)
Table 6: Musculoskeletal Diseases Market Financial Analysis 2023-2030 (US$)
Table 7: Musculoskeletal Diseases Market Driver Analysis 2023-2030 (US$)
Table 8: Musculoskeletal Diseases Market Challenges Analysis 2023-2030 (US$)
Table 9: Musculoskeletal Diseases Market Constraint Analysis 2023-2030 (US$)
Table 10: Musculoskeletal Diseases Market Supplier Bargaining Power Analysis 2023-2030 (US$)
Table 11: Musculoskeletal Diseases Market Buyer Bargaining Power Analysis 2023-2030 (US$)
Table 12: Musculoskeletal Diseases Market Threat of Substitutes Analysis 2023-2030 (US$)
Table 13: Musculoskeletal Diseases Market Threat of New Entrants Analysis 2023-2030 (US$)
Table 14: Musculoskeletal Diseases Market Degree of Competition Analysis 2023-2030 (US$)
Table 15: Musculoskeletal Diseases Market Value Chain Analysis 2023-2030 (US$)
Table 16: Musculoskeletal Diseases Market Pricing Analysis 2023-2030 (US$)
Table 17: Musculoskeletal Diseases Market Opportunities Analysis 2023-2030 (US$)
Table 18: Musculoskeletal Diseases Market Product Life Cycle Analysis 2023-2030 (US$)
Table 19: Musculoskeletal Diseases Market Supplier Analysis 2023-2030 (US$)
Table 20: Musculoskeletal Diseases Market Distributor Analysis 2023-2030 (US$)
Table 21: Musculoskeletal Diseases Market Trend Analysis 2023-2030 (US$)
Table 22: Musculoskeletal Diseases Market Size 2023 (US$)
Table 23: Musculoskeletal Diseases Market Forecast Analysis 2023-2030 (US$)
Table 24: Musculoskeletal Diseases Market Sales Forecast Analysis 2023-2030 (Units)
Table 25: Musculoskeletal Diseases Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 26: Musculoskeletal Diseases Market By Type, Revenue & Volume, By Rheumatoid Arthritis, 2023-2030 ($)
Table 27: Musculoskeletal Diseases Market By Type, Revenue & Volume, By Osteoarthritis, 2023-2030 ($)
Table 28: Musculoskeletal Diseases Market By Type, Revenue & Volume, By Osteoporosis, 2023-2030 ($)
Table 29: Musculoskeletal Diseases Market By Type, Revenue & Volume, By Psoriatic Arthritis, 2023-2030 ($)
Table 30: Musculoskeletal Diseases Market By Type, Revenue & Volume, By Ankylosing Spondylitis, 2023-2030 ($)
Table 31: Musculoskeletal Diseases Market, Revenue & Volume, By Treatment, 2023-2030 ($)
Table 32: Musculoskeletal Diseases Market By Treatment, Revenue & Volume, By Biologics, 2023-2030 ($)
Table 33: Musculoskeletal Diseases Market By Treatment, Revenue & Volume, By Corticosteroids, 2023-2030 ($)
Table 34: Musculoskeletal Diseases Market By Treatment, Revenue & Volume, By Parathyroid Hormone, 2023-2030 ($)
Table 35: Musculoskeletal Diseases Market By Treatment, Revenue & Volume, By Protein Therapy, 2023-2030 ($)
Table 36: Musculoskeletal Diseases Market By Treatment, Revenue & Volume, By Selective Estrogen Receptor Modulators, 2023-2030 ($)
Table 37: Musculoskeletal Diseases Market, Revenue & Volume, By musculoskeletal system, 2023-2030 ($)
Table 38: Musculoskeletal Diseases Market By musculoskeletal system, Revenue & Volume, By Joints, 2023-2030 ($)
Table 39: Musculoskeletal Diseases Market By musculoskeletal system, Revenue & Volume, By Ligaments, 2023-2030 ($)
Table 40: Musculoskeletal Diseases Market By musculoskeletal system, Revenue & Volume, By Muscles, 2023-2030 ($)
Table 41: Musculoskeletal Diseases Market By musculoskeletal system, Revenue & Volume, By Nerves, 2023-2030 ($)
Table 42: Musculoskeletal Diseases Market By musculoskeletal system, Revenue & Volume, By Tendons, 2023-2030 ($)
Table 43: North America Musculoskeletal Diseases Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 44: North America Musculoskeletal Diseases Market, Revenue & Volume, By Treatment, 2023-2030 ($)
Table 45: North America Musculoskeletal Diseases Market, Revenue & Volume, By musculoskeletal system, 2023-2030 ($)
Table 46: South america Musculoskeletal Diseases Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 47: South america Musculoskeletal Diseases Market, Revenue & Volume, By Treatment, 2023-2030 ($)
Table 48: South america Musculoskeletal Diseases Market, Revenue & Volume, By musculoskeletal system, 2023-2030 ($)
Table 49: Europe Musculoskeletal Diseases Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 50: Europe Musculoskeletal Diseases Market, Revenue & Volume, By Treatment, 2023-2030 ($)
Table 51: Europe Musculoskeletal Diseases Market, Revenue & Volume, By musculoskeletal system, 2023-2030 ($)
Table 52: APAC Musculoskeletal Diseases Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 53: APAC Musculoskeletal Diseases Market, Revenue & Volume, By Treatment, 2023-2030 ($)
Table 54: APAC Musculoskeletal Diseases Market, Revenue & Volume, By musculoskeletal system, 2023-2030 ($)
Table 55: Middle East & Africa Musculoskeletal Diseases Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 56: Middle East & Africa Musculoskeletal Diseases Market, Revenue & Volume, By Treatment, 2023-2030 ($)
Table 57: Middle East & Africa Musculoskeletal Diseases Market, Revenue & Volume, By musculoskeletal system, 2023-2030 ($)
Table 58: Russia Musculoskeletal Diseases Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 59: Russia Musculoskeletal Diseases Market, Revenue & Volume, By Treatment, 2023-2030 ($)
Table 60: Russia Musculoskeletal Diseases Market, Revenue & Volume, By musculoskeletal system, 2023-2030 ($)
Table 61: Israel Musculoskeletal Diseases Market, Revenue & Volume, By Type, 2023-2030 ($)
Table 62: Israel Musculoskeletal Diseases Market, Revenue & Volume, By Treatment, 2023-2030 ($)
Table 63: Israel Musculoskeletal Diseases Market, Revenue & Volume, By musculoskeletal system, 2023-2030 ($)
Table 64: Top Companies 2023 (US$) Musculoskeletal Diseases Market, Revenue & Volume
Table 65: Product Launch 2023-2030 Musculoskeletal Diseases Market, Revenue & Volume
Table 66: Mergers & Acquistions 2023-2030 Musculoskeletal Diseases Market, Revenue & Volume
List of Figures:
Figure 1: Overview of Musculoskeletal Diseases Market 2023-2030
Figure 2: Market Share Analysis for Musculoskeletal Diseases Market 2023 (US$)
Figure 3: Product Comparison in Musculoskeletal Diseases Market 2023-2030 (US$)
Figure 4: End User Profile for Musculoskeletal Diseases Market 2023-2030 (US$)
Figure 5: Patent Application and Grant in Musculoskeletal Diseases Market 2013-2023* (US$)
Figure 6: Top 5 Companies Financial Analysis in Musculoskeletal Diseases Market 2023-2030 (US$)
Figure 7: Market Entry Strategy in Musculoskeletal Diseases Market 2023-2030
Figure 8: Ecosystem Analysis in Musculoskeletal Diseases Market 2023
Figure 9: Average Selling Price in Musculoskeletal Diseases Market 2023-2030
Figure 10: Top Opportunites in Musculoskeletal Diseases Market 2023-2030
Figure 11: Market Life Cycle Analysis in Musculoskeletal Diseases Market
Figure 12: GlobalBy Type Musculoskeletal Diseases Market Revenue, 2023-2030 ($)
Figure 13: GlobalBy Treatment Musculoskeletal Diseases Market Revenue, 2023-2030 ($)
Figure 14: GlobalBy musculoskeletal system Musculoskeletal Diseases Market Revenue, 2023-2030 ($)
Figure 15: Global Musculoskeletal Diseases Market - By Geography
Figure 16: Global Musculoskeletal Diseases Market Value & Volume, By Geography, 2023-2030 ($)
Figure 17: Global Musculoskeletal Diseases Market CAGR, By Geography, 2023-2030 (%)
Figure 18: North America Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 19: US Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 20: US GDP and Population, 2023-2030 ($)
Figure 21: US GDP – Composition of 2023, By Sector of Origin
Figure 22: US Export and Import Value & Volume, 2023-2030 ($)
Figure 23: Canada Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 24: Canada GDP and Population, 2023-2030 ($)
Figure 25: Canada GDP – Composition of 2023, By Sector of Origin
Figure 26: Canada Export and Import Value & Volume, 2023-2030 ($)
Figure 27: Mexico Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 28: Mexico GDP and Population, 2023-2030 ($)
Figure 29: Mexico GDP – Composition of 2023, By Sector of Origin
Figure 30: Mexico Export and Import Value & Volume, 2023-2030 ($)
Figure 31: South America Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 32: Brazil Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 33: Brazil GDP and Population, 2023-2030 ($)
Figure 34: Brazil GDP – Composition of 2023, By Sector of Origin
Figure 35: Brazil Export and Import Value & Volume, 2023-2030 ($)
Figure 36: Venezuela Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 37: Venezuela GDP and Population, 2023-2030 ($)
Figure 38: Venezuela GDP – Composition of 2023, By Sector of Origin
Figure 39: Venezuela Export and Import Value & Volume, 2023-2030 ($)
Figure 40: Argentina Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 41: Argentina GDP and Population, 2023-2030 ($)
Figure 42: Argentina GDP – Composition of 2023, By Sector of Origin
Figure 43: Argentina Export and Import Value & Volume, 2023-2030 ($)
Figure 44: Ecuador Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 45: Ecuador GDP and Population, 2023-2030 ($)
Figure 46: Ecuador GDP – Composition of 2023, By Sector of Origin
Figure 47: Ecuador Export and Import Value & Volume, 2023-2030 ($)
Figure 48: Peru Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 49: Peru GDP and Population, 2023-2030 ($)
Figure 50: Peru GDP – Composition of 2023, By Sector of Origin
Figure 51: Peru Export and Import Value & Volume, 2023-2030 ($)
Figure 52: Colombia Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 53: Colombia GDP and Population, 2023-2030 ($)
Figure 54: Colombia GDP – Composition of 2023, By Sector of Origin
Figure 55: Colombia Export and Import Value & Volume, 2023-2030 ($)
Figure 56: Costa Rica Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 57: Costa Rica GDP and Population, 2023-2030 ($)
Figure 58: Costa Rica GDP – Composition of 2023, By Sector of Origin
Figure 59: Costa Rica Export and Import Value & Volume, 2023-2030 ($)
Figure 60: Europe Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 61: U.K Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 62: U.K GDP and Population, 2023-2030 ($)
Figure 63: U.K GDP – Composition of 2023, By Sector of Origin
Figure 64: U.K Export and Import Value & Volume, 2023-2030 ($)
Figure 65: Germany Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 66: Germany GDP and Population, 2023-2030 ($)
Figure 67: Germany GDP – Composition of 2023, By Sector of Origin
Figure 68: Germany Export and Import Value & Volume, 2023-2030 ($)
Figure 69: Italy Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 70: Italy GDP and Population, 2023-2030 ($)
Figure 71: Italy GDP – Composition of 2023, By Sector of Origin
Figure 72: Italy Export and Import Value & Volume, 2023-2030 ($)
Figure 73: France Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 74: France GDP and Population, 2023-2030 ($)
Figure 75: France GDP – Composition of 2023, By Sector of Origin
Figure 76: France Export and Import Value & Volume, 2023-2030 ($)
Figure 77: Netherlands Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 78: Netherlands GDP and Population, 2023-2030 ($)
Figure 79: Netherlands GDP – Composition of 2023, By Sector of Origin
Figure 80: Netherlands Export and Import Value & Volume, 2023-2030 ($)
Figure 81: Belgium Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 82: Belgium GDP and Population, 2023-2030 ($)
Figure 83: Belgium GDP – Composition of 2023, By Sector of Origin
Figure 84: Belgium Export and Import Value & Volume, 2023-2030 ($)
Figure 85: Spain Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 86: Spain GDP and Population, 2023-2030 ($)
Figure 87: Spain GDP – Composition of 2023, By Sector of Origin
Figure 88: Spain Export and Import Value & Volume, 2023-2030 ($)
Figure 89: Denmark Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 90: Denmark GDP and Population, 2023-2030 ($)
Figure 91: Denmark GDP – Composition of 2023, By Sector of Origin
Figure 92: Denmark Export and Import Value & Volume, 2023-2030 ($)
Figure 93: APAC Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 94: China Musculoskeletal Diseases Market Value & Volume, 2023-2030
Figure 95: China GDP and Population, 2023-2030 ($)
Figure 96: China GDP – Composition of 2023, By Sector of Origin
Figure 97: China Export and Import Value & Volume, 2023-2030 ($) Musculoskeletal Diseases Market China Export and Import Value & Volume, 2023-2030 ($)
Figure 98: Australia Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 99: Australia GDP and Population, 2023-2030 ($)
Figure 100: Australia GDP – Composition of 2023, By Sector of Origin
Figure 101: Australia Export and Import Value & Volume, 2023-2030 ($)
Figure 102: South Korea Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 103: South Korea GDP and Population, 2023-2030 ($)
Figure 104: South Korea GDP – Composition of 2023, By Sector of Origin
Figure 105: South Korea Export and Import Value & Volume, 2023-2030 ($)
Figure 106: India Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 107: India GDP and Population, 2023-2030 ($)
Figure 108: India GDP – Composition of 2023, By Sector of Origin
Figure 109: India Export and Import Value & Volume, 2023-2030 ($)
Figure 110: Taiwan Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 111: Taiwan GDP and Population, 2023-2030 ($)
Figure 112: Taiwan GDP – Composition of 2023, By Sector of Origin
Figure 113: Taiwan Export and Import Value & Volume, 2023-2030 ($)
Figure 114: Malaysia Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 115: Malaysia GDP and Population, 2023-2030 ($)
Figure 116: Malaysia GDP – Composition of 2023, By Sector of Origin
Figure 117: Malaysia Export and Import Value & Volume, 2023-2030 ($)
Figure 118: Hong Kong Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 119: Hong Kong GDP and Population, 2023-2030 ($)
Figure 120: Hong Kong GDP – Composition of 2023, By Sector of Origin
Figure 121: Hong Kong Export and Import Value & Volume, 2023-2030 ($)
Figure 122: Middle East & Africa Musculoskeletal Diseases Market Middle East & Africa 3D Printing Market Value & Volume, 2023-2030 ($)
Figure 123: Russia Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 124: Russia GDP and Population, 2023-2030 ($)
Figure 125: Russia GDP – Composition of 2023, By Sector of Origin
Figure 126: Russia Export and Import Value & Volume, 2023-2030 ($)
Figure 127: Israel Musculoskeletal Diseases Market Value & Volume, 2023-2030 ($)
Figure 128: Israel GDP and Population, 2023-2030 ($)
Figure 129: Israel GDP – Composition of 2023, By Sector of Origin
Figure 130: Israel Export and Import Value & Volume, 2023-2030 ($)
Figure 131: Entropy Share, By Strategies, 2023-2030* (%) Musculoskeletal Diseases Market
Figure 132: Developments, 2023-2030* Musculoskeletal Diseases Market
Figure 133: Company 1 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 134: Company 1 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 135: Company 1 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 136: Company 2 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 137: Company 2 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 138: Company 2 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 139: Company 3 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 140: Company 3 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 141: Company 3 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 142: Company 4 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 143: Company 4 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 144: Company 4 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 145: Company 5 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 146: Company 5 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 147: Company 5 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 148: Company 6 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 149: Company 6 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 150: Company 6 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 151: Company 7 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 152: Company 7 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 153: Company 7 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 154: Company 8 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 155: Company 8 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 156: Company 8 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 157: Company 9 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 158: Company 9 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 159: Company 9 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 160: Company 10 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 161: Company 10 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 162: Company 10 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 163: Company 11 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 164: Company 11 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 165: Company 11 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 166: Company 12 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 167: Company 12 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 168: Company 12 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 169: Company 13 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 170: Company 13 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 171: Company 13 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 172: Company 14 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 173: Company 14 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 174: Company 14 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)
Figure 175: Company 15 Musculoskeletal Diseases Market Net Revenue, By Years, 2023-2030* ($)
Figure 176: Company 15 Musculoskeletal Diseases Market Net Revenue Share, By Business segments, 2023 (%)
Figure 177: Company 15 Musculoskeletal Diseases Market Net Sales Share, By Geography, 2023 (%)